As SARMs have become more popular, concerns have emerged regarding their safety and their effects on the body. Some started questioning their potential impact on red blood cell count. We’ll see whether SARMs can influence red blood cell count and evaluate the scientific evidence surrounding this topic.
Understanding Red Blood Cells
Red blood cells (RBCs) play a vital role in our circulatory system by transporting oxygen throughout the body. Hemoglobin, their main constituent, binds to oxygen in the lungs and delivers it to various tissues, ensuring proper oxygenation and overall health.
Maintaining an optimal red blood cell count is crucial for the proper functioning of the body. Too few RBCs can lead to a condition called anemia, which results in inadequate oxygen supply to tissues, leading to fatigue, weakness, and other health issues. Conversely, an excessive number of red blood cells can lead to conditions such as polycythemia, which can cause blood viscosity problems and increase the risk of cardiovascular complications.
Regular blood tests can measure the red blood cell count, along with other parameters like hemoglobin levels and hematocrit (the proportion of blood volume occupied by RBCs). These tests help diagnose various conditions, monitor treatment effectiveness, and provide valuable insights into a person’s overall health.
SARMs and Androgen Receptors
SARMs function by selectively binding to androgen receptors in the body, influencing gene expression and promoting anabolic effects in specific tissues like muscle and bone. Unlike anabolic steroids, SARMs are designed to have a higher affinity for androgen receptors in these tissues, minimizing their impact on other organs and reducing unwanted side effects.
SARMs and Red Blood Cell Count
Although SARMs primarily target androgen receptors in muscle and bone tissue, some studies suggest that they may indirectly affect red blood cell production. However, it is crucial to acknowledge that the current scientific evidence on this subject is limited and inconclusive.
One possible mechanism through which SARMs could potentially impact RBC count is by stimulating the production of erythropoietin (EPO). EPO, a hormone produced by the kidneys, regulates the production of red blood cells. Some researchers speculate that certain SARMs may increase EPO levels, leading to an elevated RBC count.
Nonetheless, it is important to note that most studies investigating the effects of SARMs on red blood cell count have been conducted in animals or in vitro, with limited human data available. Additionally, factors such as dosage, duration of use, and specific SARMs employed can significantly influence the outcomes. Consequently, drawing definitive conclusions about the impact of SARMs on RBC count in humans remains challenging.
Anecdotal Evidence
Reports of elevated red blood cell count from using SARMs are extremely rare (I’ve never stumbled upon one). I guess if you use high dosages of SARMs for long periods of time it can happen (especially if used alongside steroids), but for people using low to moderate dosages for 8 to 12 weeks cycles it should not be a concern.
